Myriad Genetics Stock (NASDAQ: MYGN) stock price, news, charts, stock research, profile.
You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.
Other companies in Myriad Genetics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Replimune Group (NASDAQ:REPL) and Syndax Pharmaceuticals (NASDAQ:SNDX).
Myriad Genetics has a consensus price target of $22.82.
The stock price for Myriad Genetics (NASDAQ: MYGN) is $14.56 last updated February 14, 2025 at 6:38 PM EST.
There are no upcoming dividends for Myriad Genetics.
Myriad Genetics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Myriad Genetics.
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.